Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic Melanoma.

Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic Melanoma. Clin Adv Hematol Oncol. 2020 Jul;18(7):408-410 Authors: Sznol M PMID: 32903252 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research